H, F. H., JA, B., EA, S., & GA, A. (2022). Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly(Ethylene Glycol) Antibodies. Regenerative engineering and translational medicine, 8(1), 32. https://doi.org/10.1007/s40883-021-00198-y
Chicago Style (17th ed.) CitationH, Freire Haddad, Burke JA, Scott EA, and Ameer GA. "Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly(Ethylene Glycol) Antibodies." Regenerative Engineering and Translational Medicine 8, no. 1 (2022): 32. https://doi.org/10.1007/s40883-021-00198-y.
MLA (9th ed.) CitationH, Freire Haddad, et al. "Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly(Ethylene Glycol) Antibodies." Regenerative Engineering and Translational Medicine, vol. 8, no. 1, 2022, p. 32, https://doi.org/10.1007/s40883-021-00198-y.